Overview Financials News + Filings Key Docs Charts Ownership Insiders |
ZYNEX INC (ZYXI)
|
Add to portfolio |
|
|
Price: |
$10.03
| | Metrics |
OS: |
35.9
|
M
| |
|
|
Market cap: |
$360
|
M
| |
|
|
Net cash:
|
$1.59
|
M
| |
$0.04
|
per share
|
EV:
|
$359
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 158.2 | 130.3 | 80.1 | 45.5 | 31.9 | 23.4 | 13.3 | 11.6 |
Revenue growth | 21.4% | 62.6% | 76.2% | 42.5% | 36.2% | 76.0% | 14.4% | 4.7% |
Cost of goods sold | 114.7 | 93.7 | 17.4 | 8.8 | 6.0 | 4.8 | 3.5 | 4.9 |
Gross profit | 43.5 | 36.6 | 62.7 | 36.7 | 25.9 | 18.6 | 9.8 | 6.7 |
Gross margin | 27.5% | 28.1% | 78.3% | 80.6% | 81.1% | 79.4% | 73.6% | 57.6% |
Selling, general and administrative | | | | | | 9.7 | 9.2 | 9.2 |
Sales and marketing | 67.1 | 54.3 | 34.1 | 14.9 | 6.5 | | | |
General and administrative | 36.1 | 26.3 | 18.3 | 10.7 | 9.0 | | | |
EBITA | 22.9 | 22.4 | 10.2 | 11.1 | 10.4 | 9.0 | 0.7 | -2.4 |
EBITA margin | 14.5% | 17.2% | 12.7% | 24.3% | 32.5% | 38.3% | 5.1% | -20.8% |
Amortization of intangibles | | | | | | 0.0 | 0.0 | 0.1 |
EBIT | 22.9 | 22.4 | 10.2 | 11.1 | 10.4 | 8.9 | 0.6 | -2.5 |
EBIT margin | 14.5% | 17.2% | 12.7% | 24.3% | 32.5% | 38.2% | 4.8% | -21.3% |
Pre-tax income | 22.2 | 22.3 | 10.2 | 11.9 | 10.2 | 7.5 | 0.1 | -3.0 |
Income taxes | 5.2 | 5.2 | 1.1 | 2.4 | 0.7 | 0.1 | 0.0 | -0.1 |
Tax rate | 23.2% | 23.2% | 10.6% | 20.5% | 6.5% | 1.7% | 17.9% | 1.9% |
Net income | 17.0 | 17.1 | 9.1 | 9.5 | 9.6 | 7.4 | 0.1 | -2.9 |
Net margin | 10.8% | 13.1% | 11.3% | 20.9% | 29.9% | 31.4% | 0.5% | -25.2% |
|
Diluted EPS | $0.44 | $0.44 | $0.26 | $0.28 | $0.28 | $0.22 | $0.00 | ($0.09) |
Shares outstanding (diluted) | 39.1 | 39.2 | 34.9 | 34.0 | 34.0 | 33.2 | 31.3 | 31.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|